EAS Advanced Course: Paris, France
2017-06-21October 05-06, 2017 - Paris, France. EAS aims to promote education and training in the prevention and care of atherosclerosis and its clinical manifestations, and equally in basic science, in the atherosclerosis field.
Organised by EAS and University Hospital Pitié Salpêtrière.
Chairpersons: Eric Bruckert and Eran Leitersdorf
Preliminary Programme
Novel Diagnostics towards improved patient stratifi cation and targeted therapy
Topics
- Precision Cardiovascular Medicine: an unmet need or just a fashion?
- Human Genetics from validation of novel cardiovascular drug targets to molecular diagnosis
- Do Novel Biomarkers improve cardiovascular risk stratifi cation?
- Is there a role for Advanced Atherosclerosis Imaging in targeted
cardiovascular therapy?
- Nutrigenomics for prevention and treatment of obesity
- How is the Pharmaceutical Industry preparing for the new era of Precision
Cardiovascular Medicine?
Therapeutic Considerations based on the genetic background and disease phenotypes
Topics
- Identifi cation of novel targets in Hypertension and priorities for drug development
- Can we refi ne strategy on HDL by new pharmacological approaches?
- Will precision medicine help tailor dyslipidaemia treatment?
Official webpage:
http://www.eas-society.org/page/advanced_courses
Cikk értékelése | Eddig 1 felhasználó értékelte a cikket. |
Hozzászólások